NEWSNATIONNOW (Josie Fischels) - GLP-1-driven vitamin deficiency linked to rare brain disorder: Study
Researchers found a rare but potentially life-threatening brain disorder in a small number of people taking Ozempic, Wegovy and similar drugs.
Researchers found a rare but potentially life-threatening brain disorder in a small number of people taking Ozempic, Wegovy and similar drugs.
Poop is the new hot health topic. But getting a little too into our BMs can drag us back down into bad bathroom habits.
Author Da'Shaun L. Harrison claims that the use of GLP-1 weight loss medications operates as 'body fascism.' #fox #foxnews #media #breakingnews #us #usa #new #news #breaking #dashaunharrison #harrison #glp1 #weightloss #weightlossmedication #health #healthnews #obesity #bodyimage #medicine #healthcare #medicalnews #diet #wellness #controversy #healthyliving #prescriptiondrugs Don’t just watch Fox News—be part of it. Become a Fox News Patriot today. https://youtube.com/foxnews/join
Kids with obesity-related conditions like high cholesterol or sleep apnea were substantially more likely to be prescribed GLP-1s than those without.
Obstructive sleep apnea affects nearly one billion adults worldwide and is linked to serious health problems.
Watch Final Hours https://ept.ms/WatchFullFinalHours Up to $20,000 of Free Silver: https://ept.ms/3biH9MN How badly do you want that perfect beach body? Some are willing to get liposuction and have someone shuffle their own fat around. But how about getting one’s body enhanced by injecting fat from dead people? Is that a bit much? Well, that’s what’s happening in the cosmetics industry. Now, you might ask: Why do they need to use fat from cadavers? Why not just liposuction one area, and move it to another? Here’s the twist: the rise of GLP-1 weight loss drugs are leaving people without enough fat to move around. Let’s go through it all together. #botox #cosmeticsurgery #fat #factsmatter © All Rights Reserved.
Researchers found liver fat dropped by 67% among people on a ketogenic diet
A neuron known for stimulating hunger is actually triggered into overdrive by semaglutide.
Demand for Ozempic, Wegovy and similar drugs is soaring, but some employers say the cost is becoming too much to absorb.
Experts say there isn't enough evidence to prove weight-loss drugs are the sole reason retailers are reducing larger sizes.